iBinom (Big Data, Biotechnology) — Funding, Investors & Signals 2026

iBinom

Founded 2012 1 employees Seed Total: $400.00K Big Data, Biotechnology

is a startup founded in 2012 with a mission to establish a presence in the emerging clinical next-gen sequencing market. The company has introduced a user-friendly, rapid, and cost-effective human genome interpretation service through its iBinom Saas platform. This platform offers an end-to-end solution for interpreting genomes to diagnose both Mendelian and non-Mendelian diseases, tumor profiling, and drug response biomarker discovery studies. iBinom leverages Amazon EC2 and its proprietary algorithms, alongside machine learning technology, to simplify and expedite inherited disease diagnostics. The company's approach includes a unique design for medical reports. iBinom secured a $300.00K investment in a Seed Round in December 2014. With this funding, the company is poised to make impactful strides in bringing its services to the medical field and addressing the diagnostic and treatment challenges faced by seriously ill patients. The company operates within the Big Data and Biotechnology industries.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	••••••	-		01 Dec 2014
Seed Round	••••••	3		01 Sep 2013

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

••••••

01 Dec 2014

Seed Round

••••••

01 Sep 2013

FAQ About iBinom

Aiming to get a foothold in the emerging clinical next-gen sequencing market iBinom launched a simple, fast and affordable human genome interpretation service. iBinom Saas platform is an end-to-end genome interpretation solution for diagnostics of Mendelian and non-Mendelian diseases, tumor profilin...

iBinom was founded in 2012.

iBinom operates in the following industries: Big Data, Biotechnology.

iBinom has approximately 1 employees.

iBinom has completed 2 funding rounds, raising a total of $400.00K. The latest funding stage is Seed.

Top alternatives and competitors to iBinom include Cypher Genomics, Personal Genome Diagnostics, Blueprint Genetics, Arpeggi Inc, Farsight Genome Systems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

iBinom and Cypher Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

iBinom

General Information

Track iBinom

Discover More

About iBinom

Funding Rounds & Investors (2)

iBinom Alternatives & Competitors

FAQ About iBinom

Don't just browse. Track.